🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,94 USD
Máx. histórico
156,45
72 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,08%
Rango 52 semanas
84,35 – 156,92
Variación hoy
-2,28%
Cierre anterior
150,36
Rango de hoy
146,55 – 153,37
Volumen hoy
11.428.734
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,42 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/12/1974 | 1,74 | 1,79 | 1,73 | 1,78 | +1,91% | 3,42% | 1.875.082 |
| 16/12/1974 | 1,77 | 1,78 | 1,73 | 1,74 | -1,31% | 3,00% | 1.165.795 |
| 13/12/1974 | 1,76 | 1,80 | 1,76 | 1,77 | +0,56% | 2,45% | 1.633.622 |
| 12/12/1974 | 1,78 | 1,81 | 1,75 | 1,76 | -1,12% | 2,98% | 3.240.835 |
| 11/12/1974 | 1,74 | 1,79 | 1,74 | 1,78 | +2,68% | 2,86% | 2.644.733 |
| 10/12/1974 | 1,70 | 1,76 | 1,70 | 1,73 | +3,58% | 3,71% | 1.494.029 |
| 09/12/1974 | 1,60 | 1,67 | 1,59 | 1,67 | +4,13% | 4,75% | 2.241.043 |
| 06/12/1974 | 1,67 | 1,67 | 1,58 | 1,60 | -3,96% | 5,35% | 2.158.042 |
| 05/12/1974 | 1,73 | 1,73 | 1,67 | 1,67 | -3,64% | 3,64% | 799.834 |
| 04/12/1974 | 1,70 | 1,74 | 1,70 | 1,73 | +1,95% | 2,14% | 1.377.072 |
| 03/12/1974 | 1,73 | 1,73 | 1,69 | 1,70 | -2,28% | 2,11% | 1.565.712 |
| 02/12/1974 | 1,80 | 1,80 | 1,73 | 1,74 | -4,20% | 3,86% | 1.094.112 |
| 29/11/1974 | 1,79 | 1,83 | 1,78 | 1,82 | +1,48% | 2,78% | 973.382 |
| 27/11/1974 | 1,76 | 1,80 | 1,76 | 1,79 | +2,46% | 2,07% | 2.290.090 |
| 26/11/1974 | 1,75 | 1,78 | 1,70 | 1,75 | -0,19% | 4,54% | 1.931.674 |
| 25/11/1974 | 1,71 | 1,75 | 1,70 | 1,75 | +2,33% | 2,91% | 1.162.022 |
| 22/11/1974 | 1,70 | 1,73 | 1,70 | 1,71 | +1,77% | 1,95% | 1.203.523 |
| 21/11/1974 | 1,61 | 1,68 | 1,60 | 1,68 | +4,32% | 5,14% | 1.501.574 |
| 20/11/1974 | 1,60 | 1,64 | 1,59 | 1,61 | +0,62% | 3,11% | 1.418.573 |
| 19/11/1974 | 1,62 | 1,62 | 1,58 | 1,60 | -1,83% | 2,86% | 4.078.397 |
| 18/11/1974 | 1,68 | 1,68 | 1,63 | 1,63 | -5,39% | 3,15% | 2.301.408 |
| 15/11/1974 | 1,78 | 1,78 | 1,72 | 1,72 | -4,41% | 3,16% | 2.954.102 |
| 14/11/1974 | 1,84 | 1,86 | 1,79 | 1,80 | -2,16% | 3,78% | 1.580.803 |
| 13/11/1974 | 1,88 | 1,91 | 1,84 | 1,84 | -1,94% | 3,88% | 2.361.773 |
| 12/11/1974 | 1,90 | 1,93 | 1,86 | 1,88 | -1,22% | 3,66% | 1.256.342 |
| 11/11/1974 | 1,89 | 1,92 | 1,88 | 1,90 | +0,70% | 2,28% | 879.062 |
| 08/11/1974 | 1,87 | 1,91 | 1,83 | 1,89 | +1,06% | 4,08% | 1.199.750 |
| 07/11/1974 | 1,80 | 1,89 | 1,80 | 1,87 | +4,06% | 5,35% | 1.776.989 |
| 06/11/1974 | 1,80 | 1,88 | 1,79 | 1,80 | -0,19% | 4,79% | 2.075.040 |
| 05/11/1974 | 1,69 | 1,80 | 1,68 | 1,80 | +6,47% | 6,87% | 1.610.986 |